Effectiveness and Safety of Rivaroxaban in Patients With Cancer-Associated Venous Thrombosis.
Conclusions: Event rates observed in this rivaroxaban-treated cohort were overall consistent with previous studies of patients with rivaroxaban- and warfarin-managed CAT.
PMID: 29752323 [PubMed - in process]
Source: Journal of the National Comprehensive Cancer Network : JNCCN - Category: Cancer & Oncology Tags: J Natl Compr Canc Netw Source Type: research
More News: Atrial Fibrillation | Bleeding | Cancer | Cancer & Oncology | Coumadin | Emergency Medicine | Gastroenterology | Pulmonary Thromboembolism | Study | Thrombosis | Warfarin